Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/661962


Republic of Korea Diabetes Care Devices Investment Opportunities, Analysis and Forecasts


Description: Republic of Korea Diabetes Care Devices Investment Opportunities, Analysis and Forecasts

Summary

This report is an essential source for in-depth information and data relating to the Republic of Korea diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in Republic of Korea

Scope

- The report provides diabetes care devices information broken down into detailed categories and segments in Republic of korea.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in Republic of Korea.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of the Markets Covered in the Report 11
3.1 Diabetes Care Devices 11
3.2 Glucose Monitoring 11
3.2.1 Blood Glucose Meter 11
3.2.2 Blood Glucose Strips 11
3.3 Insulin Delivery 11
3.3.1 Insulin Pen 11
3.3.2 Insulin Pump 11
3.3.3 Insulin Syringes 11
4 Healthcare Sector Review 13
4.1 Healthcare Expenditure 13
4.2 Healthcare Infrastructure 16
4.3 Healthcare Policy 20
5 Regulation System 21
5.1 Medical Equipment Approval Process 21
5.1.1 Classification 21
5.1.2 Premarket Notification for Class I Devices 22
5.1.3 Pre-market Approval for Class II, III and IV Devices 22
5.1.4 License Fee 23
5.1.5 License Application Processing Duration 23
5.2 Post-market Surveillance 24
6 Pricing and Reimbursement 25
7 Distribution Structure 28
7.1 Distribution Structure 28
8 Diabetes Care Devices In Republic of Korea 29
8.1 Diabetes Care Devices Cross Country Comparison (2000-2012) 29
8.2 Diabetes Care Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 30
8.3 Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2000-2012 34
8.4 Diabetes Care Devices, Republic of Korea, Company Share (2006-2007) 37
9 Glucose Monitoring In Republic of Korea 38
9.1 Glucose Monitoring Overall Revenue (2000-2012) 38
9.2 Glucose Monitoring Overall Volume (2000-2012) 40
9.3 Glucose Monitoring Average Price (2000-2012) 42
9.4 Glucose Monitoring Distribution Share (2006-2007) 43
9.5 Glucose Monitoring, Republic of Korea, Company Share (2006-2007) 44
10 Insulin Delivery In Republic of Korea 45
10.1 Insulin Delivery Overall Revenue (2000-2012) 45
10.2 Insulin Delivery Overall Volume (2000-2012) 47
10.3 Insulin Delivery Average Price (2000-2012) 48
10.4 Insulin Delivery Distribution Share (2006-2007) 49
10.5 Insulin Delivery, Republic of Korea, Company Share (2006-2007) 50
11 F. Hoffmann-La Roche Ltd. Company Profile 51
11.1 Company Overview 51
11.2 Value Chain Analysis 51
11.2.1 Manufacturing 52
11.2.2 Product Development 52
11.2.3 Sales and Marketing 53
12 LifeScan, Inc. Company Profile 55
12.1 Company Overview 55
12.1.1 LifeScan, Inc. Pipeline Products by Equipment Type 56
12.1.2 LifeScan, Inc. Pipeline Products by Development Stage 56
12.1.3 LifeScan, Inc. Pipeline Products by Therapy Area 56
12.1.4 LifeScan, Inc. Pipeline Products by Clinical Trials 56
12.1.5 LifeScan, Inc. Pipeline Products by News Summary 56
13 Abbott Laboratories Company Profile 57
13.1 Company Overview 57
13.2 Value Chain Analysis 57
13.2.1 Manufacturing 58
13.2.2 Product Development 58
13.2.3 Sales and Marketing 59
13.2.4 Abbott Laboratories Pipeline Products by Equipment Type 59
13.2.5 Abbott Laboratories Pipeline Products by Development Stage 60
13.2.6 Abbott Laboratories Pipeline Products by Therapy Area 60
13.2.7 Abbott Laboratories Pipeline Products by Clinical Trials 60
13.2.8 Abbott Laboratories Pipeline Products by News Summary 60
14 Bayer HealthCare AG Company Profile 61
14.1 Company Overview 61
14.2 Value Chain Analysis 61
14.2.1 Manufacturing 62
14.2.2 Product Development 62
14.2.3 Sales and Marketing 63
14.3 Bayer HealthCare AG Pipeline Products 63
14.3.1 Bayer HealthCare AG Pipeline Products by Equipment Type 63
14.3.2 Bayer HealthCare AG Pipeline Products by Development Stage 64
14.3.3 Bayer HealthCare AG Pipeline Products by Therapy Area 64
14.3.4 Bayer HealthCare AG Pipeline Products by News Summary 64
15 Novo Nordisk A/S Company Profile 65
15.1 Company Overview 65
15.1.1 Novo Nordisk A/S Pipeline Products by Equipment Type 66
15.1.2 Novo Nordisk A/S Pipeline Products by Development Stage 66
15.1.3 Novo Nordisk A/S Pipeline Products by Therapy Area 66
15.1.4 Novo Nordisk A/S Pipeline Products by Clinical Trials 66
16 Eli Lilly and Company Company Profile 67
16.1 Company Overview 67
16.2 Value Chain Analysis 67
16.2.1 Manufacturing 68
16.2.2 Product Development 68
16.2.3 Sales and Marketing 69
16.2.4 Eli Lilly and Company Pipeline Products by Equipment Type 70
16.2.5 Eli Lilly and Company Pipeline Products by Development Stage 70
16.2.6 Eli Lilly and Company Pipeline Products by Therapy Area 70
17 Abbott Korea Limited Company Profile 71
17.1 Company Overview 71
18 Shin Chang Medical Co., Ltd. Company Profile 72
18.1 Company Overview 72
19 Shina Corporation Company Profile 73
19.1 Company Overview 73
20 Appendix 74
20.1 Global Markets Direct Research Methodology 74
20.2 Coverage 75
20.3 Secondary Research 75
20.4 Primary Research 76
20.5 Models 76
20.6 Forecasts 77
20.7 Expert Panels 77
20.8 Currency Conversion 78
20.9 Contact Us 79
20.10 Disclaimer 79

Executive Summary

1.2 List of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007 14
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006 15
Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007 26
Figure 4: Medical Device Pricing System in Republic of Korea, 2007 27
Figure 5: Diabetes Care Devices Cross Country Comparison (2000-2012) 29
Figure 6: Diabetes Care Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 30
Figure 7: Diabetes Care Devices, Republic of Korea, Portfolio Analysis, 2000-2012 31
Figure 8: Diabetes Care Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 32
Figure 9: Diabetes Care Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 33
Figure 10: Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2000-2012 34
Figure 11: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2007 35
Figure 12: Diabetes Care Devices, Republic of Korea, Category Volume (Units), Forecast, 2007-2012 36
Figure 13: Diabetes Care Devices, Republic of Korea, Company Share (%), 2007 37
Figure 14: Glucose Monitoring, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 38
Figure 15: Glucose Monitoring, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 39
Figure 16: Glucose Monitoring, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 40
Figure 17: Glucose Monitoring, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 41
Figure 18: Glucose Monitoring, Republic of Korea, Company Share (%), 2007 44
Figure 19: Insulin Delivery, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 20: Insulin Delivery, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 21: Insulin Delivery, Republic of Korea, Company Share (%), 2007 50
Figure 22: F. Hoffmann-La Roche Ltd Value Chain Analysis 51
Figure 23: Abbott Laboratories Value Chain Analysis 57
Figure 24: Bayer HealthCare AG Value Chain Analysis 61
Figure 25: Eli Lilly and Company Value Chain Analysis 67
Figure 26: Global Markets Direct Methodology 74


Companies Mentioned F. Hoffmann-La Roche Ltd. LifeScan, Inc. Abbott Laboratories Bayer HealthCare AG Novo Nordisk A/S Eli Lilly and Company Abbott Korea Limited Shin Chang Medical Co., Ltd. Shina Corporation


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/661962

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 10:04:58
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Republic of Korea Diabetes Care Devices Investment Opportunities, Analysis and Forecasts
Web Address:
http://www.researchandmarkets.com/reports/661962
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 10:04:58

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)